Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation.

Kim DJ, Lee DH, Ahn S, Jung J, Kiem S, Kim SW, Shin JG.

J Clin Pharm Ther. 2019 Jun 22. doi: 10.1111/jcpt.12995. [Epub ahead of print]

PMID:
31228353
2.

Rapidly Fatal Emphysematous Osteomyelitis with Multiple Septic Emboli and Liver Abscess Caused by Klebsiella pneumoniae.

Kim YK, Jo KM, Jang JH, Heo CM, Lee JH, Park JH, Kim S, Jang HJ, Kim HK, Kiem S.

Infect Chemother. 2018 Sep;50(3):268-273. doi: 10.3947/ic.2018.50.3.268.

3.

Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics.

Song KH, Jung SI, Lee S, Park S, Kim ES, Park KH, Park WB, Choe PG, Kim YK, Kwak YG, Kim YS, Jang HC, Kiem S, Kim HI, Kim HB; Korea INfectious Diseases (KIND) study group.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):67-74. doi: 10.1007/s10096-018-3392-6. Epub 2018 Sep 30.

PMID:
30269181
4.

Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections.

Kim YK, Lee DH, Jeon J, Jang HJ, Kim HK, Jin K, Lim SN, Lee SS, Park BS, Kim YW, Shin JG, Kiem S.

Clin Ther. 2018 Aug;40(8):1384-1395. doi: 10.1016/j.clinthera.2018.07.001. Epub 2018 Aug 7.

PMID:
30093133
5.

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.

Lee MS, Oh JY, Kang CI, Kim ES, Park S, Rhee CK, Jung JY, Jo KW, Heo EY, Park DA, Suh GY, Kiem S.

Infect Chemother. 2018 Jun;50(2):160-198. doi: 10.3947/ic.2018.50.2.160. Review.

6.

Maternal, Fetal, and Neonatal Outcomes in Pregnant Dengue Patients in Mexico.

Machain-Williams C, Raga E, Baak-Baak CM, Kiem S, Blitvich BJ, Ramos C.

Biomed Res Int. 2018 Jan 21;2018:9643083. doi: 10.1155/2018/9643083. eCollection 2018.

7.

Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.

Kim YK, Song SA, Lee JN, Oh M, Jo KM, Kim HJ, Lee JH, Park J, Jang HJ, Kim HK, Kiem S.

J Hosp Infect. 2018 Aug;99(4):405-412. doi: 10.1016/j.jhin.2017.10.017. Epub 2017 Oct 27.

PMID:
29111353
8.

Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.

Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB; Korea INfectious Diseases (KIND) study group.

Clin Microbiol Infect. 2018 Feb;24(2):152-158. doi: 10.1016/j.cmi.2017.07.001. Epub 2017 Jul 8.

9.

agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.

Kang CK, Kim YK, Jung SI, Park WB, Song KH, Park KH, Choe PG, Jang HC, Lee S, Kim YS, Kwak YG, Kwon KT, Kiem S, Kim CJ, Kim ES, Kim HB; Korea INfectious Diseases (KIND) study group.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2187-2191. doi: 10.1007/s10096-017-3044-2. Epub 2017 Jun 21.

PMID:
28639163
10.

Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.

Kim YK, Lee JH, Lee HK, Chung BC, Yu SJ, Lee HY, Park JH, Kim S, Kim HK, Kiem S, Jang HJ.

J Thorac Dis. 2017 Mar;9(3):555-567. doi: 10.21037/jtd.2017.02.61.

11.

Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.

Lee DH, Kim YK, Jin K, Kang MJ, Joo YD, Kim YW, Moon YS, Shin JG, Kiem S.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02185-16. doi: 10.1128/AAC.02185-16. Print 2017 May.

12.

Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.

Song KH, Jung SI, Lee S, Park S, Kiem SM, Lee SH, Kwak YG, Kim YK, Jang HC, Kim YS, Kim HI, Kim CJ, Park KH, Kim NJ, Oh MD, Kim HB; Korea INfectious Diseases (KIND) study group.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):285-294. doi: 10.1007/s10096-016-2799-1. Epub 2016 Oct 6.

PMID:
27714592
13.

Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections.

Kim YK, Jung JA, Choi HK, Bae IG, Choi WS, Hur J, Jin SJ, Kim SW, Kwon KT, Lee SR, Shin JG, Kiem S; Pharmacokinetics-Pharmacodynamics of Antibiotics Working Group under Korean Society for Chemotherapy.

Infect Chemother. 2016 Sep;48(3):209-215. doi: 10.3947/ic.2016.48.3.209. Epub 2016 Sep 6.

14.

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.

Kim CJ, Choi WS, Jung Y, Kiem S, Seol HY, Woo HJ, Choi YH, Son JS, Kim KH, Kim YS, Kim ES, Park SH, Yoon JH, Choi SM, Lee H, Oh WS, Choi SY, Kim NJ, Choi JP, Park SY, Kim J, Jeong SJ, Lee KS, Jang HC, Rhee JY, Kim BN, Bang JH, Lee JH, Park S, Kim HY, Choi JK, Wi YM, Choi HJ.

Clin Microbiol Infect. 2016 Oct;22(10):880-886. doi: 10.1016/j.cmi.2016.07.017. Epub 2016 Jul 27.

15.

Validation of non-REM sleep stage decoding from resting state fMRI using linear support vector machines.

Altmann A, Schröter MS, Spoormaker VI, Kiem SA, Jordan D, Ilg R, Bullmore ET, Greicius MD, Czisch M, Sämann PG.

Neuroimage. 2016 Jan 15;125:544-555. doi: 10.1016/j.neuroimage.2015.09.072. Epub 2015 Oct 24.

PMID:
26596551
16.

Population pharmacokinetics of levofloxacin in Korean patients.

Kiem S, Ryu SM, Lee YM, Schentag JJ, Kim YW, Kim HK, Jang HJ, Joo YD, Jin K, Shin JG, Ghim JL.

J Chemother. 2016 Aug;28(4):308-13. doi: 10.1179/1973947815Y.0000000033.

PMID:
25976699
17.

Interpretation of Epithelial Lining Fluid Concentrations of Antibiotics against Methicillin Resistant Staphylococcus aureus.

Kiem S, Schentag JJ.

Infect Chemother. 2014 Dec;46(4):219-25. doi: 10.3947/ic.2014.46.4.219. Epub 2014 Dec 29. Review.

18.

Attraction, recruitment and distribution of health professionals in rural and remote Australia: early results of the Rural Health Professionals Program.

Morell AL, Kiem S, Millsteed MA, Pollice A.

Hum Resour Health. 2014 Mar 6;12:15. doi: 10.1186/1478-4491-12-15.

19.

Correlations between Microbiological Outcomes and Clinical Responses in Patients with Severe Pneumonia.

Kiem S, Schentag JJ.

Infect Chemother. 2013 Sep;45(3):283-91. doi: 10.3947/ic.2013.45.3.283. Epub 2013 Sep 27.

20.

The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study.

Kim CJ, Kim HB, Oh MD, Kim Y, Kim A, Oh SH, Song KH, Kim E, Cho Y, Choi Y, Park J, Kim BN, Kim NJ, Kim KH, Lee E, Jun JB, Kim Y, Kiem S, Choi H, Choo E, Sohn KM, Lee S, Chang H, Bang J, Lee S, Lee J, Park S, Jeon M, Yun N; KIND Study group (Korea Infectious Diseases Study group).

BMC Infect Dis. 2014 Nov 14;14:590. doi: 10.1186/s12879-014-0590-4.

21.

Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis status in healthy males.

Kiem SA, Andrade KC, Spoormaker VI, Holsboer F, Czisch M, Sämann PG.

Psychoneuroendocrinology. 2013 Aug;38(8):1338-48. doi: 10.1016/j.psyneuen.2012.11.021. Epub 2012 Dec 29.

PMID:
23279846
22.

Effects of rapid eye movement sleep deprivation on fear extinction recall and prediction error signaling.

Spoormaker VI, Schröter MS, Andrade KC, Dresler M, Kiem SA, Goya-Maldonado R, Wetter TC, Holsboer F, Sämann PG, Czisch M.

Hum Brain Mapp. 2012 Oct;33(10):2362-76. doi: 10.1002/hbm.21369. Epub 2011 Aug 8.

PMID:
21826762
23.
24.

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.

Brink AJ, Richards GA, Schillack V, Kiem S, Schentag J.

Int J Antimicrob Agents. 2009 May;33(5):432-6. doi: 10.1016/j.ijantimicag.2008.10.005. Epub 2008 Dec 16.

PMID:
19091521
25.

Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Kiem S, Schentag JJ.

Antimicrob Agents Chemother. 2008 Jan;52(1):24-36. Epub 2007 Sep 10. Review. No abstract available.

26.

Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.

Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH.

J Korean Med Sci. 2006 Apr;21(2):188-92.

27.
28.

Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface.

Kiem S, Oh WS, Peck KR, Lee NY, Lee JY, Song JH, Hwang ES, Kim EC, Cha CY, Choe KW.

J Korean Med Sci. 2004 Dec;19(6):779-82.

29.

Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.

Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, Kiem S, Kim YS, Oh WS, Peck KR, Lee NY; Asian Network for Surveillance of Resistant Pathogens Study Group.

Antimicrob Agents Chemother. 2004 Dec;48(12):4926-8.

30.

Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis.

Lee H, Song JH, Kim SW, Oh WS, Jung SI, Kiem S, Peck KR, Lee NY.

Int J Antimicrob Agents. 2004 Mar;23(3):307-10.

PMID:
15164975
31.

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).

Kim YS, Kiem S, Yun HJ, Jung SI, Oh WS, Kim SW, Peck KR, Lee NY, Song JH.

J Korean Med Sci. 2003 Jun;18(3):319-24.

32.

One-point population analysis and effect of osmolarity on detection of hetero-vancomycin-resistant Staphylococcus aureus.

Jung SI, Kiem S, Lee NY, Kim YS, Oh WS, Cho HL, Peck KR, Song JH.

J Clin Microbiol. 2002 Apr;40(4):1493-5.

Supplemental Content

Support Center